Multiple Dose Pharmacokinetics of Tapentadol Oral Solution for the Treatment of Moderate to Severe Acute Pain in Children Aged 2 to <7 Years

BACKGROUND: This prospective, open-label trial was conducted to fulfil a post-approval commitment made to the competent authorities to extend the indication of the strong opioid analgesic tapentadol hydrochloride oral solution (OS) to the pediatric population. PATIENTS AND METHODS: The trial assesse...

Descripción completa

Detalles Bibliográficos
Autores principales: Jończyk, Renata, Beuter, Christoph, Bulawa, Beata, Buller, Stefan, Eibl, Christoph, Elling, Christian, Gautrois, Michael, Rengelshausen, Jens, Schmidt, Carsten, Thömmes, Guido, Khalil, Feras
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9531608/
https://www.ncbi.nlm.nih.gov/pubmed/36203787
http://dx.doi.org/10.2147/JPR.S364902

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9531608/
https://www.ncbi.nlm.nih.gov/pubmed/36203787
http://dx.doi.org/10.2147/JPR.S364902

Ejemplares similares